News & Highlights

from August 2022

In this video Micha Yin-Zheng Cheng, MD, MPH, MS, a resident in the University of California San Francisco (UCSF) Department of Urology discusses the background of the UCSF UReTER

The California Institute for Regenerative Medicine (CIRM) approved investing more than $3.8 million in a Phase 1 clinical trial to create a stem cell-based therapy for urethral stricture disease led by Wake Forest University Health Sciences and UCSF Urology, which will serve as the main clinical site. UCSF Urology is a leading center internationally for the treatment and study of urethral stricture disease (https://expertscape.com/ex/urethral+stricture).

Tweets

Media Contact

Elizabeth Fernandez
UCSF Department of Urology
San Francisco, CA 94143
[email protected]
415/514-1592